In Depth 23 May 2022
The coming of age of European synthetic biology
…Freemont, a professor at Imperial College London, is a senior figure in synthetic biology in the UK as a founder of the university’s Centre for Synthetic Biology and the synbio…
Search Results for: London
In Depth 26 Jan 2024
Long COVID: are we on the verge of a breakthrough?
…worsen with time, according to research. A study conducted by Imperial College London, found that mental health and health-related quality of life were worse among patients who experienced persistent symptoms…
News and Trends 3 Jan 2018
What Are Clinical Trials and Why Do We Do Them?
…trial system isn’t testing drugs as rigorously as it should. A study by King’s College London and the London School of Economics found that 57% of cancer drugs did not…
Best in Biotech 5 Sep 2023
Five recent advancements in ovarian cancer research over the past year
…who have been diagnosed with HGSOC. The research, conducted by Imperial College London in England, examined tumors from 242 patients with high-grade serous ovarian cancer, where they compared them before…
ADVERTISEMENT
Best in Biotech 12 Dec 2017
Grab the Tissues: Here are the 8 Biggest European Biotech Clinical Failures of 2017
…in 2020. On top of this, concerns over the clinical trial process were raised by a study at King’s College London and the London School of Economics. It found that…
News and Trends 18 Oct 2017
Biotech Crosses the Channel to Raise €9.7M for its Diagnostics Tools
Novacyt will use the money raised on the AIM market, London, to expand its manufacturing capacity and continue research looking into new techniques. Novacyt specializes in diagnostic tools for a…
Podcast 27 Oct 2023
Beyond Biotech podcast 69 – improving access to cell and gene therapy
This week, our guest on the podcast is Jason C. Foster, CEO of Ori Biotech. Ori is a London, U.K. and New Jersey, U.S. based manufacturing technology company pioneering flexible…
In Depth 20 Apr 2020
How Has Coronavirus Affected Europe’s Biotech Stocks?
…stock Genedrive, which achieved an astonishing 280% price increase on the London Stock Exchange on a single day in late March. This was when the company reported it was close…
Best in Biotech 26 Mar 2018
The 10 Biotech Venture Capital Firms in Europe to Watch in 2018
…Dekeyser after the launch. From London, Medicxi launched a $300M (about €240M) fund in June that counts with money from Google’s Verily, Novartis, and the European Investment Fund. Medicxi…
In Depth 8 Feb 2021
How Next-Generation Gene Therapy Tackles Complex Diseases
…“We’ve been constrained with the things we can do with gene therapy,” said Dmitry Kuzmin, Managing Partner at 4BIO Capital, a London-based VC that specifically invests in advanced therapies. “If…
News and Trends 10 Oct 2024
Second biotech IPO boom of the year: what does it mean for the industry?
…the US opens the door for UK biotechs looking to hit Nasdaq. This is increasingly their preferred location to list rather than the London Stock Exchange, because there’s more appetite…
News and Trends 25 Oct 2018
Parkinson’s Disease Gene Therapy Clinical Trial Launched in UK
A gene therapy for Parkinson’s disease developed by Swiss biotech Axovant has been used on the first patient in a Phase I/II trial at University College London. Parkinson’s disease is…
